Augustin, M. et al. 1993. Phorbol-12-Myristate-13-Acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T cell activation. J. Invest. Dermatol. 100(3):275-281. |
Azuma, et al. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature, vol. 366:76-79. |
Freedman et al. 1987. B7, a B cell restricted antigen that identifies preactivated b cells. J. Immunol. 139:3260-3267. |
Freeman, G.J. et al. ,“Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation,” Science 262:909-911 (1993). |
Freeman et al. 1992. The gene for B7, a costimulatory signal for T cell activation, maps to chromosomal region 3q13.3-3q21 Blood. 79:489-494. |
Gimmi et al. 1991. B cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secretE interleukin 2. PNAS 88:6575-6579. |
Harding et al. 1992. CD28-mediated signaling costimulates murine T cells and prevent induction of anergy in T cell clones. Nature 356:607-609. |
Hathcock et al. 1993. Identification of an alternative CTLA4 ligand costimulatory for T cell activation. Science. 262:905-907. |
Linsley et al. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleikin 2 mRNA accumulation. J. Exp. Med. 173:721-730. |
Selvakumar et al. 1992. Genomic organization and chromosomal location of the human gene encoding the B lymphocyte activation antigen B7. Immunogenetics. 36:175-181. |
Tan et al. 1993. Induction of alloantigen specific hyporesponsiveness in human T lymphocytes by blocking interactions of CD28 with its natural ligand B7/BB. J. Exp. Med. 177:165-173. |